- For Print
- October 31, 2011
Eisai expresses its heartfelt sympathies to all the people affected by the recent floods in Thailand.
Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, “Eisai”) announced today that it has made a US$100,000 donation to the Thai Red Cross Society to support the victims of the Thailand flood disaster and help with recovery efforts in the affected area.
Furthermore, Eisai's Thai subsidiary will provide pharmaceutical products and relief supplies while carrying out activities to support local patients and their families as well as the wider public, in line with Eisai's human health care (hhc) mission.
Eisai sincerely hopes that its support will help the people affected by this disaster and prays for the speedy recovery of the afflicted region.
[ Please refer to the following notes for further information on Eisai's Thai subsidiary
Eisai (Thailand) Marketing Co., Ltd. ]
Public Relations Department,
Eisai Co., Ltd.
< Notes to editors >
About Eisai's Thai Subsidiary Eisai (Thailand) Marketing Co., Ltd.
Eisai (Thailand) Marketing Co., Ltd. (Headquarters: Bangkok, President: Thaweesak Sithongsurapana) was established in 1989 as the Thai pharmaceutical sales subsidiary of Eisai Co. Ltd. The company's sales activities are focused primarily on neurology products such as Aricept® and Methycobal® and gastroenterological products such as Pariet®. Eisai (Thailand) Marketing Co., Ltd. also oversees Eisai's activities in the Indochina region, which includes Vietnam, Cambodia and Myanmar, and represents one of the key operations in Eisai's ASEAN business.